This is the authors' abstract. We don't add key points for this paper.
On the basis of the most current evidence, there is overwhelming support of take-home naloxone programs associated with decreased mortality among those who abuse opioids. As a result, there is an implication for a practice change that take-home naloxone programs should be more widely implemented throughout communities as a method of decreasing mortality associated with opioid overdoses. It is recommended that further research is done examining the cost-effectiveness of these programs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chimbar et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: